Forest Ray, PhD,  —

The U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Dysport (abobotulinumtoxin A) for the treatment of upper limb spasticity in children with cerebral palsy. This follows its previous approval for treating patients of the same age with lower limb spasticity — and makes Dysport…

A prototype of a portable data logger that can be attached to a wheelchair’s control mechanism may lead to tailored training and safer wheelchair use for people with dyskinetic cerebral palsy, according to a recent study. The results, “Development of a Data Logger for Capturing Human-Machine Interaction in…